1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional" is currently closed and not accepting applications.
Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional is sponsored by National Institutes of Health (NIH). Seeks to broaden the types of knowledge, skills, expertise, experience, and perspectives in ELSI research.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
BBAER Program Opens Applications for Organizations Advancing ELSI Research in Genetics and Genomics BBAER Program Opens Applications for Organizations Advancing ELSI Research in Genetics and Genomics Applications are open for the Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional (RFA-HG-24-026).
This opportunity supports organizations interested in advancing scholarship and capacity in ELSI research related to advances in genetics and genomics. Eligible applicants must be domestic organizations located in the United States and its territories that received less than $30 million per year in total NIH funding for the past three fiscal years (FY 2023–2025).
Eligible applicants may propose partnerships with other organizations that receive more than $30 million per year in NIH funding. Students and trainees are not eligible to apply. Organizations outside of the United States are not eligible to apply.
The goals of the Building Partnerships and Broadening Perspectives to Advance ELSI Research (BBAER) Program are to: Enhance ELSI research teams through partnerships with relevant communities Build ELSI research capacity Expand the ELSI workforce Collectively, these goals will broaden the types of knowledge, skills, expertise, experience, and perspectives brought to bear in ELSI research This program is funded by the National Human Genome Research Institute’s (NHGRI) ELSI Research Program.
Since 1990, the ELSI Research Program has funded research, research training, resource development, and other activities addressing the ethical, legal, and social implications of advances in genetics and genomics. Detailed application requirements and program information are available in the Notice of Funding Opportunity RFA-HG-24-026 , which includes an overview diagram of all application elements.
Frequently Asked Questions and a recorded program presentation are also available online. Per NIH notice NOT-OD-26-019, letters of intent are no longer required. For additional questions or to discuss organizational interests, please contact Dr. Rene Sterling at rene.
sterling@nih. gov. Notice of Funding Opportunity RFA-HG-24-026 BBAER Frequently Asked Questions BBAER Pre-Application Recorded Webinar AIM-AHEAD Research Spotlight Series: Showcasing Innovative Research Across the Consortium Find out more about how AIM-AHEAD CLINAQ Program participants Kalyani Narra (MD) and Dhruvangi Sharma (PhD) are advancing healthcare through AI/ML-driven research.
2026 AIM-AHEAD Annual Meeting Brings Together Leaders and Researchers Advancing the Future of AI in Biomedical Research and Healthcare Attendees gathered for the 2026 AIM-AHEAD Annual Meeting, held July 6–9 in San Diego, California, for three days of networking, collaboration, and discussions on the future of artificial intelligence in biomedical research and healthcare.
AIM-AHEAD Research Spotlight Series: Showcasing Innovative Research Across the Consortium Find out more about how AIM-AHEAD Federated Network Program participants Leyla Warsame (MD) and Patricia Mabry (PhD) are advancing healthcare through AI/ML-driven research.
According to the current listing, eligibility includes: Nonprofit organizations conducting ELSI research. Confirm the full requirements in the official notice before applying.
The current listing shows up to $850,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was August 2, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article